Pharmablock Sciences to early redeem convertible bonds
Pharmablock Sciences (Nanjing) will early redeem its convertible bonds, known as "Yaoshi convertible bonds," at a price of 100.62 yuan per bond, covering the face value plus accrued interest. The redemption conditions were satisfied on August 14, 2025, when the company's stock price exceeded 130% of the current conversion price for at least 15 trading days within a 30-day period.
Trading of the convertible bonds will halt on September 15, 2025, and conversion to shares will cease on September 18, 2025. The official redemption date is September 18, 2025, with investor redemption funds expected by September 25, 2025. The company explicitly warns bondholders to convert their bonds into shares by the deadline to avoid mandatory redemption at the announced price, as the current secondary market price may differ significantly.
The "Yaoshi convertible bonds" will be delisted from the Shenzhen Stock Exchange upon completion of the redemption. The latest conversion price for the bonds is 33.61 yuan per share as of the announcement date.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Pharmablock Sciences (Nanjing) publishes news
Free account required • Unsubscribe anytime